EditPep
Berkeley
About EditPep
Editpep is a biotechnology business. It creates a class of peptides capable of delivering CRISPR enzymes into previously untranslatable clinically relevant cell types.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.2M
- Last round: Undisclosed (Dec 2024)
- Website: editpep.bio
- Phone: +1 5106797827
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/editpep-123216 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.